ANDAINJECTIONINJECTABLE
Approved
Nov 2025
Lifecycle
Post-LOE
Competitive Pressure
30/100
Mechanism of Action
(alpha-adrenergic action) and an inotropic stimulator of the heart and dilator of coronary arteries (beta-adrenergic action).
(alpha-adrenergic action) and an inotropic stimulator of the heart and dilator of coronary arteries (beta-adrenergic action).